• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH 0.00% 0.4¢

ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH 12:08 123 32K
12:08 Last post  RebekahChambers Comments Created with Sketch.  123  Views Created with Sketch.  32K 
ATH 11:35 0 115
11:35 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  115 
ATH
Good to look at the reference study by Wenning et al
07:42 4 1.0K
Industrials SECTOR NEWS

One Click Group surpasses $3M in revenue YTD with 40% growth

1CG
24 Jul 2024
ONE CLICK GROUP LIMITED
07:42 Last post  Mateo335 Comments Created with Sketch.  4  Views Created with Sketch.  1.0K 
ATH 20/07/24 2 954
20/07/24 Last post  Gordon2020 Comments Created with Sketch.  2  Views Created with Sketch.  954 
ATH
Value of company post Positive phase 2 trial results
20/07/24 5 1.8K
20/07/24 Last post  Gordon2020 Comments Created with Sketch.  5  Views Created with Sketch.  1.8K 
ATH 19/07/24 0 245
19/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  245 
ATH 18/07/24 1 623
18/07/24 Last post  pivalde Comments Created with Sketch.  1  Views Created with Sketch.  623 
ATH 17/07/24 75 22K
17/07/24 Last post  Scottsmyname Comments Created with Sketch.  75  Views Created with Sketch.  22K 

See All Discussions arrow Created with Sketch.

Timeline

Alterity Therapeutics to Present at MST Financial Webinar
24 Jul 11:15
 
Notice Under Section 708A
19 Jul 12:19
 
Application for quotation of securities - ATH
19 Jul 12:17
 
Proposed issue of securities - ATH
18 Jul 12:16
 
Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
17 Jul 10:20
 
Trading Halt
15 Jul 09:25
 
View More arrow Created with Sketch.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $23.94M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $60.47K 15.08M

Buyers (Bids)

No. Vol. Price($)
103 87983906 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 30464687 17
View Market Depth
Last trade - 11.52am 24/07/2024 (20 minute delay) ?
Last
0.4¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.4¢ 5059240
Last updated 11.38am 24/07/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.